Schoeneck James A's Form 4 filing
Kyntra Bio, Inc.KYNB · filed Mar 24, 2025
- Accession no.
- 0001415889-25-008823
- Filed
- Mar 24, 2025, 9:00 AM ET
- Trade date
- Mar 20-21, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $105.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schoeneck James ACIK 0001420987 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.3499 to $0.3593. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.3341 to $0.3466. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.